IPO Guru

IPO Listed — 07 Jan 2026

Listing Price: ₹90 (+0% vs ₹90)

View GMP History →
Modern Diagnostic & Research Centre

Modern Diagnostic & Research Centre SME IPO Review

Modern Diagnostic & Research Centre SME IPO has been reviewed by 1 analyst, and the overall consensus is Strong Apply — carrying a score of 100. Out of the 1 analysts who have covered this IPO, 1 recommend subscribing — reflecting a mixed view from the analyst community.

The issue is priced in the band of ₹₹85 to ₹90 per share , with a minimum application size of 1600 shares . Subscription ran from 31 Dec 2025 to 02 Jan 2026. As of now, the grey market premium (GMP) for Modern Diagnostic & Research Centre SME IPO is quoting at ₹14 (16%), which gives a preliminary sense of how the street is pricing the listing — though GMP is unofficial and can swing sharply before the listing date. Scroll down for the full analyst breakdown and analyst-wise verdicts.

General Review

Modern Diagnostic IPO bidding started from Dec 31, 2025 and ended on Jan 2, 2026. The allotment for Modern Diagnostic IPO was finalized on Jan 5, 2026. Modern Diagnostic IPO will list on BSE SME with a tentative listing date fixed as Jan 7, 2026.

Disclaimer: This review is an AI summary derived from the reviews of all analysts.

Analyst Sentiment

Analytical Score

How it's calculated?
Strong Apply
100 / 100

Recommend Subscribe

Based on 1 analyst reviews

1 / 1

Higher consensus indicates broader analyst agreement.

Analyst Review

Analyst Verdict View
Apply

Latest IPO Reviews

Frequently Asked Questions

Should I apply for Modern Diagnostic & Research Centre SME IPO?

Based on analyst coverage tracked on this page, the overall verdict for Modern Diagnostic & Research Centre SME IPO is Strong Apply. Out of 1 analyst who have reviewed this IPO, 1 recommend subscribing. Always cross-check with the full analyst reviews below and consult a SEBI-registered advisor before making any investment decision.

What does the score of 100 mean for Modern Diagnostic & Research Centre SME IPO?

The score of 100 is an aggregate of all analyst ratings tracked for Modern Diagnostic & Research Centre SME IPO. A score in this range indicates strong analyst confidence — most analysts are recommending a subscribe. Scroll down to read individual analyst verdicts for more context.

What was the actual listing price of Modern Diagnostic & Research Centre SME IPO?

Modern Diagnostic & Research Centre SME IPO listed on January 7, 2026 at ₹90 , against the issue price of ₹90 — a gain of +0% (₹0 per share). View the full GMP history page for day-wise pre-listing trends.

What is the price band and lot size of Modern Diagnostic & Research Centre SME IPO?

Modern Diagnostic & Research Centre SME IPO was priced at ₹₹85 to ₹90 per share. The minimum lot size is 1600 shares. Subscription ran from 31 Dec 2025 to 02 Jan 2026.

Explore Modern Diagnostic & Research Centre SME IPO Further

Track every stage of this IPO:

Discussion 0

💡
Commenting as
Markdown supported: **bold**, _italics_

No comments yet

Be the first to share your thoughts!

Advertisement
Disclaimer: Grey Market Premium (GMP) is for information purposes and is not a guarantee of listing price. Always consult your financial advisor before investing.